Dashboard PDUFA PDUFA History Dilution Watch Downside Radar Missed Milestones Earnings Big Movers Blog

🎤 Upcoming Biotech Conferences

Loading conferences...
Free to browse, no account needed Track BGM with free AI briefings, catalyst countdowns, and dilution alerts.

BGM · BGM Group Ltd.

Company guidance, FDA catalysts, dilution risk and cash runway, built from SEC, FDA and ClinicalTrials.gov filings and updated every day.

$11.5M Cash on Hand
CF+ Cash Runway
Follow BGM by email Get an email when BGM reports key news in an SEC filing, pushes back a promised milestone, files for a stock offering, lands on the Downside Radar or has an FDA decision. Free, no account needed.

We send one confirmation email first. Only emails about BGM, unsubscribe in one click. Privacy

📄 Latest SEC Filings in Plain English

Each summary is written by AI from the filing itself, and one that names a number or a name the filing does not contain is not shown. Quarterly and annual reports are listed by period. Read the filing before acting on it.

💰 Cash Runway & Dilution Risk

BGM holds $11.5M in cash and short-term investments and its operations are currently cash-flow neutral or positive.

Dilution pressure: 10 · Low

Recent financing filings on SEC EDGAR:

Source: SEC EDGAR (XBRL cash flow and financing filings). Dilution Watch: every company ranked → · Get an alert when BGM files for a raise →

👥 Who Owns BGM

Insiders 0% Other 5%+ holders 100% Institutions (6 holders) 0% Public and other holders 0%
HolderTypeShares% of sharesAs of
AIX Inc. 5%+ holder (13D) 69,995,661 195.79% 2024-12-27
Low Thia Yang 5%+ holder (13D) 38,165,290 106.76% 2025-05-19
AIFU Inc. 5%+ holder (13D) 16,529,330 46.24% 2025-05-23

Share count 35,750,000 (latest 10-Q/10-K). Insiders: each officer's, director's and 10% owner's latest Form 3, 4 or 5, direct and indirect shares; options are not counted. 5%+ holders: latest Schedule 13D or 13G of each holder above 5%. Institutions: the total held by all 13F filers (Yahoo Finance); the table lists the largest. Sources have different dates, so the split is approximate. Source: SEC EDGAR.

Get the full BGM picture

The 7-day free trial adds AI daily briefings, sentiment tracking, trial enrollment progress and email alerts for BGM and every other ticker you follow. Card required, cancel anytime.

Start 7-day free trial →

Data: SEC EDGAR, FDA, ClinicalTrials.gov, Yahoo Finance • Informational purposes only, not investment advice. • All tracked stocks A–Z

This data is for informational purposes only, not investment advice. BioRadar does not provide buy/sell recommendations. Past performance does not guarantee future results. Always do your own due diligence.